Does adjuvant alpha-interferon improve outcome when combined with total skin irradiation for mycosis fungoides?

British Journal of Dermatology

Volumn 156, Issue 1, 2007, Pages 57-61

  Roberge, D ^a   Muanza, T ^a   Blake, G ^a   Shustik, C ^a   Vuong, T ^a   Freeman, C R ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Interferon; Mycosis fungoides; Radiotherapy

Indexed keywords

RECOMBINANT ALPHA2B INTERFERON;

ADULT; AGED; ANOREXIA; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CHILL; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DERMATITIS; DISEASE FREE SURVIVAL; FEMALE; FEVER; FOLLOW UP; HUMAN; LEUKOPENIA; MALE; MYALGIA; MYCOSIS FUNGOIDES; NAUSEA; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; THROMBOCYTOPENIA; TOTAL SKIN ELECTRON IRRADIATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DRUG ERUPTIONS; FEMALE; HUMANS; INTERFERON TYPE I, RECOMBINANT; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 33845527311     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07559.x     Document Type: Article

References (21)

1. Siegel RS, Pandolfino T, Guitart J et al. Primary cutaneous T-cell lymphoma: review and current concepts. J Clin Oncol 2000; 18:2908-25.
2. Kim YH, Jensen RA, Watanabe GL et al. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis. Arch Dermatol 1996; 132:1309-13.
3. Kim YH, Liu HL, Mraz-Gernhard S et al. Long-term outcome of 525 patients with mycosis fungoides and Sézary syndrome: clinical prognostic factors and risk for disease progression. Arch Dermatol 2003; 139:857-66.
4. Quirós PA, Jones GW, Kacinski BM et al. Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides). Int J Radiat Oncol Biol Phys 1997; 38:1027-35.
5. Freeman CR, Suissa S, Shenouda G et al. Clinical experience with a single field rotational total skin electron irradiation technique for cutaneous T-cell lymphoma. Radiother Oncol 1992; 24:155-62.
6. 2-M phase of the cell cycle. Cancer Res 1987; 47:4338-41.
7. Angioli R, Sevin BU, Perras JP et al. In vitro potentiation of radiation cytotoxicity by recombinant interferons in cervical cancer cell lines. Cancer 1993; 71:3717-25.
8. Kuzel TM, Roenigk HH Jr, Samuelson E et al. Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the Sézary syndrome. J Clin Oncol 1995; 13:257-63.
9. Bunn PA Jr, Foon KA, Ihde DC et al. Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas. Ann Intern Med 1984; 101:484-7.
10. Bunn PA Jr, Hoffman SJ, Norris D et al. Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome). Ann Intern Med 1994; 121:592-602.
11. Knobler RM, Trautinger F, Radaszkiewicz T et al. Treatment of cutaneous T cell lymphoma with a combination of low-dose interferon alfa-2b and retinoids. J Am Acad Dermatol 1991; 24:247-52.
12. Suchin KR, Cucchiara AJ, Gottleib SL et al. Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution. Arch Dermatol 2002; 138:1054-60.
13. Podgorsak EB, Pla C, Pla M et al. Physical aspects of a rotational total skin electron irradiation. Med Phys 1983; 10:159-68.
14. Kaye FJ, Bunn PA Jr, Steinberg SM et al. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med 1989; 321:1784-90.
15. Jones G, McLean J, Rosenthal D et al. Combined treatment with oral etretinate and electron beam therapy in patients with cutaneous Tcell lymphoma (mycosis fungoides and Sézary syndrome). J Am Acad Dermatol 1992; 26:960-7.
16. Chinn DM, Chow S, Kim YH et al. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides. Int J Radiat Oncol Biol Phys 1999; 43:951-8.
17. Wilson LD, Jones GW, Kim D et al. Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides. J Am Acad Dermatol 2000; 43:54-60.
18. Wilson LD, Licata AL, Braverman IM et al. Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy. Int J Radiat Oncol Biol Phys 1995; 32:987-95.
19. Duvic M, Apisarnthanarax N, Cohen DS et al. Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 2003; 49:35-49.
20. Langendijk JA, de Jong MA, Leemans CR et al. Postoperative radiotherapy in squamous cell carcinoma of the oral cavity: the importance of the overall treatment time. Int J Radiat Oncol Biol Phys 2003; 57:693-700.
21. Souhami L, Corns R, Duclos M et al. Long-term results of high-dose rate brachytherapy in cervix cancer using a small number of fractions. Gynecol Oncol 2005; 97:508-13.